ANSALDI, FILIPPO
 Distribuzione geografica
Continente #
EU - Europa 27.828
NA - Nord America 3.085
AS - Asia 3.062
SA - Sud America 327
Continente sconosciuto - Info sul continente non disponibili 292
AF - Africa 52
OC - Oceania 5
Totale 34.651
Nazione #
IT - Italia 27.256
US - Stati Uniti d'America 2.871
SG - Singapore 1.256
CN - Cina 777
VN - Vietnam 494
FR - Francia 246
BD - Bangladesh 236
BR - Brasile 205
CA - Canada 89
HK - Hong Kong 88
DE - Germania 67
AR - Argentina 59
FI - Finlandia 50
GB - Regno Unito 42
JP - Giappone 31
MX - Messico 28
ID - Indonesia 26
IN - India 26
IQ - Iraq 26
NL - Olanda 26
CH - Svizzera 22
JM - Giamaica 20
HN - Honduras 19
CO - Colombia 17
CR - Costa Rica 15
ES - Italia 15
RU - Federazione Russa 14
IE - Irlanda 13
EC - Ecuador 12
PH - Filippine 12
ZA - Sudafrica 12
UA - Ucraina 11
VE - Venezuela 11
CL - Cile 10
PK - Pakistan 10
PL - Polonia 10
GT - Guatemala 9
MA - Marocco 9
TT - Trinidad e Tobago 9
SA - Arabia Saudita 8
TR - Turchia 8
NI - Nicaragua 7
NP - Nepal 7
UZ - Uzbekistan 7
DO - Repubblica Dominicana 6
KE - Kenya 6
MY - Malesia 6
PY - Paraguay 6
RO - Romania 6
SE - Svezia 6
TN - Tunisia 6
AE - Emirati Arabi Uniti 5
HR - Croazia 5
LB - Libano 5
AL - Albania 4
AU - Australia 4
EG - Egitto 4
GR - Grecia 4
OM - Oman 4
SV - El Salvador 4
TH - Thailandia 4
AZ - Azerbaigian 3
BO - Bolivia 3
ET - Etiopia 3
HU - Ungheria 3
IL - Israele 3
KR - Corea 3
PR - Porto Rico 3
PT - Portogallo 3
RS - Serbia 3
AT - Austria 2
BE - Belgio 2
BG - Bulgaria 2
BH - Bahrain 2
CI - Costa d'Avorio 2
CZ - Repubblica Ceca 2
DK - Danimarca 2
DZ - Algeria 2
EE - Estonia 2
GE - Georgia 2
GP - Guadalupe 2
IS - Islanda 2
KW - Kuwait 2
LU - Lussemburgo 2
MD - Moldavia 2
MN - Mongolia 2
PA - Panama 2
SC - Seychelles 2
SI - Slovenia 2
TG - Togo 2
AM - Armenia 1
AO - Angola 1
BY - Bielorussia 1
CW - ???statistics.table.value.countryCode.CW??? 1
CY - Cipro 1
GM - Gambi 1
GY - Guiana 1
JO - Giordania 1
KG - Kirghizistan 1
KN - Saint Kitts e Nevis 1
Totale 34.348
Città #
Genova 15.580
Genoa 6.762
Rapallo 2.510
Vado Ligure 1.787
San Jose 852
Singapore 591
Ashburn 278
Bordighera 271
Lauterbourg 218
Ho Chi Minh City 162
Beijing 137
New York 124
Santa Clara 108
Hanoi 97
Hong Kong 81
Council Bluffs 78
Los Angeles 60
Frankfurt am Main 54
Milan 54
Dallas 49
Helsinki 46
Phoenix 35
Chicago 33
Rome 32
Tokyo 27
Houston 26
Da Nang 25
São Paulo 23
Tianjin 23
Zurich 22
Orem 21
Buffalo 20
Haiphong 18
Mexico City 18
San Francisco 17
Toronto 17
Amsterdam 16
Boardman 16
Charlotte 16
Atlanta 15
Kingston 15
Brooklyn 14
London 14
Montreal 14
Naples 14
Turin 14
Brasília 12
Dublin 12
San José 12
The Bronx 12
Baghdad 11
Philadelphia 11
Biên Hòa 10
City of London 10
Las Vegas 10
Hải Dương 9
Jacksonville 9
Denver 8
Guatemala City 8
Palermo 8
Warsaw 8
Can Tho 7
Chennai 7
Dhaka 7
Florence 7
Managua 7
Miami 7
Paris 7
Rio de Janeiro 7
Salt Lake City 7
Bologna 6
Cardiff 6
Castelluccio dei Sauri 6
Dayton 6
Detroit 6
Guangzhou 6
Johannesburg 6
Louisville 6
Memphis 6
Pasadena 6
Quito 6
Quảng Ngãi 6
Rochester 6
San Pedro Sula 6
Verona 6
Baltimore 5
Calgary 5
Catania 5
Columbus 5
Guayaquil 5
Indpls 5
Jeddah 5
Lincoln 5
Minneapolis 5
Nairobi 5
Newark 5
Nha Trang 5
Parma 5
Piscataway 5
Porto Alegre 5
Totale 30.782
Nome #
Adjuvanted seasonal influenza vaccines and perpetual viral metamorphosis: the importance of cross-protection 506
Surveillance of hospital-acquired infections in Liguria, Italy: results from a regional prevalence study in adult and paediatric acute-care hospitals. 266
Influenza vaccination among healthcare workers in Italy. 261
Fifteen years of epidemiologic, virologic and syndromic influenza surveillance: A focus on type B virus and the effects of vaccine mismatch in Liguria region, Italy 258
Incidence and outcome of invasive candidiasis in intensive care units (icus) in europe: Results of the eucandicu project 249
A new assay for hepatitis C virus (HCV) core antigen detection: an alternative to nucleic acid technologies in positive or indeterminate anti-HCV subjects? 231
Carriage of Streptoccoccus pneumoniae 7 years after implementation of vaccination program in a population with very high and long-lasting coverage, Italy. 225
Epidemiological changes after PCV7 implementation in Italy: perspective for new vaccines. 223
Antigenic characterisation of influenza B virus with a new microneutralisation assay: comparison to haemagglutination and sequence analysis 222
Impaired response to influenza vaccine associated with persistent memory B cell depletion in non-Hodgkin's lymphoma patients treated with rituximab-containing regimens. 221
Assessment of knowledge, attitudes, and propensity towards HPV vaccine of young adult students in Italy 220
Characteristics of staphylococcus aureus bacteraemia and predictors of early and late mortality 219
2015/16 seasonal vaccine effectiveness against hospitalisation with influenza a(H1N1)pdm09 and B among elderly people in Europe: Results from the I-MOVE+ project 217
Adherence to international and national recommendations for the prevention of surgical site infections in Italy: results from an observational prospective study in elective surgery. 215
Ras-induced resistance to lapatinib is overcome by MEK inhibition 210
Vaccine-preventable infections in Systemic Lupus Erythematosus 206
Immunization Campaigns and Strategies against Human Papillomavirus in Italy: The Results of a Survey to Regional and Local Health Units Representatives 203
Analysis of a 3-months measles outbreak in western Liguria, Italy: Are hospital safe and healthcare workers reliable? 203
A multicenter study of septic shock due to candidemia: outcomes and predictors of mortality. 198
Synergistic interactions between HDAC and sirtuin inhibitors in human leukemia cells. 193
Clinical characteristics and predictors of mortality in cirrhotic patients with candidemia and intra-abdominal candidiasis: a multicenter study 192
A meningococcal carrier survey, in Italy 191
Effectiveness of pneumococcal vaccines in preventing pneumonia in adults, a systematic review and meta-analyses of observational studies 191
[Immunization campaign with 13-valent Pneumococcal Conjugate Vaccine in adults in Liguria Region, Italy: one year post-introduction preliminary results] 191
Adjuvants and alternative routes of administration towards the development of the ideal influenza vaccine 189
An unexpected Streptococcus pneumoniae strain. 186
[Immunization campaign with 13-valent Pneumococcal Conjugate Vaccine in adults in Liguria Region, Italy: one year post-introduction preliminary results] 184
Burden of the 1999-2008 seasonal influenza epidemics in Italy: comparison with the H1N1v (A/California/07/09) pandemic. 181
Impatto della pertosse nella popolazione e strategie di prevenzione vaccinale 181
Global reaction to the recent outbreaks of Zika virus: Insights from a Big Data analysis 180
Antibody response against heterogeneous circulating influenza virus strains elicited by MF59- and non-adjuvanted vaccines during seasons with good or partial matching between vaccine strain and clinical isolates 177
Inactivated influenza vaccines: recent progress and implications for the elderly 177
A multicenter multinational study of abdominal candidiasis: epidemiology, outcomes and predictors of mortality 177
A randomized clinical trial assessing immunogenicity and safety of a double dose of virosomal-adjuvanted influenza vaccine administered to unprimed children aged 6-35 months 176
Surgical Prevention of Arm Lymphedema After Breast Cancer Treatment 176
Seasonal and pandemic (A/H1N1 2009) MF-59-adjuvanted influenza vaccines in complete remission non-Hodgkin lymphoma patients previously treated with rituximab containing regimens. 175
Universal influenza virus vaccines: what needs to happen next? 173
Burden and prevention of hpv. Knowledge, practices and attitude assessment among pre-adolescents and their parents in Italy 172
The impact of 10-valent and 13-valent pneumococcal conjugate vaccines on hospitalization for pneumonia in children: A systematic review and meta-analysis 171
State of the Art, Unresolved Issues, and Future Research Directions in the Fight against Hepatitis C Virus: Perspectives for Screening, Diagnostics of Resistances, and Immunization 168
Molecular characterization of a new variant of rotavirus P[8]G9 predominant in a sentinel-based survey in central Italy 166
Increasing Incidence of Streptococcus pneumoniae Serotype 19A and Emergence of Two Vaccine Escape Recombinant ST695 Strains in Liguria, Italy, 7 Years after Implementation of the 7-Valent Conjugated Vaccine. 166
Neutralizing and Hemagglutination-Inhibiting Activities of Antibodies Elicited by the 2004-2005 Influenza Vaccine against Drifted Viruses. 163
Molecular characterization of influenza B viruses circulating in Northeren Italy during the 2001-2002 epidemic season 163
Carriage of Streptoccoccus pneumoniae in healthy adults aged 60 years or over in a population with very high and long-lasting pneumococcal conjugate vaccine coverage in children: rationale and perspectives for PCV13 implementation. 163
Seroprevalence of HTLV-I and HTLV-II infection among immigrants in northern Italy 162
Different seroprevalence and molecular epidemiology patterns of hepatitis C virus infection in Italy. 162
An outbreak of influenza in a residential drug-rehabilitation community 161
Seasonal influenza beginning in Europe: report from EISS. 161
Burden of rotavirus disease and cost-effectiveness of universal vaccination in the Province of Genoa (Northern Italy) 160
Antiviral activity of amantadine in elderly patients with chronic hepatitis C 160
Hepatitis A incidence and hospital-based seroprevalence in Italy: a nation-wide study 159
Hepatitis C virus in the new era: perspectives in epidemiology, prevention, diagnostics and predictors of response to therapy 158
Phase 4 randomized trial of intradermal low-antigen-content inactivated influenza vaccine versus standard-dose intramuscular vaccine in HIV-1-infected adults. 158
Epidemiology of viral respiratory tract infections in an outpatient haematology facility 158
An outbreak of hepatitis C virus in a haemodialysis unit: molecular evidence of patient-to-patient transmission 157
Patients Treated with Rituximab-Containing Immunochemotherapy Have a Significant and Prolonged Lack of Humoral Response to Influenza Vaccine Associated with a Persistent Depletion of B Memory Cells 157
Vaccinazione antinfluenzale degli operatori sanitari presso l’IRCCS AOU San Martino-IST di Genova: progetto-pilota di counselling e offerta attiva direttamente presso reparti a elevato rischio 157
Fluzone® intra-dermal (Intanza® / Istivac® Intra-dermal): An updated overview 156
Burden of rotavirus associated and non-rotavirus-associated diarrhea among nonhospitalized individuals in central Italy: a 1-year sentinel-based epidemiological and virological surveillance 156
SARS-CoV, influenza A and syncitial respiratory virus resistance against common disinfectants and ultraviolet irradiation 155
MOLECULAR AND SEROLOGICAL DIVERSITY OF NEISSERIA MENINGITIDIS CARRIER STRAINS ISOLATED FROM ITALIAN STUDENTS AGED 14-22 YEARS. 155
Direct detection of Bordetella pertussis and Bordetella parapertussis: comparison of polymerase chain reaction and culture. 154
Intradermal influenza vaccine and new devices: a promising chance for vaccine improvement 154
Immunomodulation due to plasma or plasma-platelet apheresis donation: Events occurring during donation procedures. 154
Risk factors for severe complications of the novel influenza A (H1N1): analysis of patients hospitalized in Italy. 154
Measles outbreak in Grosseto, central Italy, 2006. 153
High-dose daptomycin in documented Staphylococcus aureus infections. 153
Clinical and therapeutic aspects of candidemia: A five year single centre study 153
Fluzone® Intradermal vaccine: a promising new chance to increase the acceptability of influenza vaccination in adults 151
Infective endocarditis in elderly: An Italian prospective multi-center observational study 151
Intanza(®) 15 mcg intradermal influenza vaccine elicits cross-reactive antibody responses against heterologous A(H3N2) influenza viruses 151
Determinants of invasiveness and ability to cause invasive pneumococcal disease, pneumonia and acute otitis media of different serotypes of Streptococcus pneumoniae. 151
r-IFN alfa-2b/ribavirin combined therapy followed by low dose of IFN alfa 2b in chronic hepatitis C IFN nonresponders 150
Influenza and respiratory syncytial virus in infants and children: relationship with attendance at a paediatric emergency unit and characteristics of the circulating strains 150
Influenza Burden on Italian Paediatric Population: Five year Nation-wide Surveillance and Correlation between Epidemiological and Virological Data 149
A possible role of soluble HLA-I molecule in the immunomodulatory effects of therapeutic apheresis. 149
Pneumococcus and the elderly in Italy: A summary of available evidence regarding carriage, Clinical burden of lower respiratory tract infections and on-field effectiveness of PCV13 vaccination 149
Repeated seasonal influenza vaccination among elderly in Europe: Effects on laboratory confirmed hospitalised influenza 149
Potential effect of PCV13 introduction on Emergency Department accesses for lower respiratory tract infections in elderly and at risk adults 148
Head-to-head comparison of an intradermal and a virosome influenza vaccine in patients over the age of 60: evaluation of immunogenicity, cross-protection, safety and tolerability. 148
Influenza control in the 21st century: Optimizing protection of older adults 147
Sequentialoutbreaks of multidrug-resistant Acinetobacter baumannii in intensive care units of a tertiary referral hospital in Italy: combined molecular approach for epidemiological investigation 147
Vaccination recommendations for patients with neuromuscular disease. 146
Bacterial carriage and respiratory tract infections in subjects ≥ 60 years during an influenza season: implications for the epidemiology of Community Acquired Pneumonia and influenza vaccine effectiveness 146
Italian health care workers’ knowledge, attitudes, and practices regarding human papillomavirus infection and prevention 146
Has Clinical and Epidemiological Varicella Burden Changed over Time in Children? Overview on Hospitalizations, Comorbidities and Costs from 2010 to 2017 in Italy 146
Safety and immunogenicity of conventional subunit and MF-59 adjuvanted influenza vaccines in human immunodeficiency virus-1-seropositive patients 145
Ostreopsis ovata and human health: epidemiological and clinical features of respiratory syndrome outbreaks from a two-year syndromic surveillance, 2005-06, in north-west Italy 145
Economic Impact of Inter-Regional Health Mobility In The Oldest European Administrative Region: A Starting Point For Changing Organizational Model? 145
New A/H3N2 influenza variant: a small genetic evolution but a heavy burden on the Italian population during the 2004-2005 season 144
Human papillomavirus vaccination: what is the best choice? A comparison by means of decisional model 143
Silymarin and S-adenosyl-L-methionine (SAMe): two promising pharmacological agents in case of chronic alcoholic hepathopathy. A review and a point of view. 143
Universal childhood immunisation against Streptococcus pneumoniae: the five-year experience of Liguria, Italy 143
Simultaneous Detection of Anti-HCV Antibody and HCV Core Antigen. 142
Nosocomial candidemia in patients admitted to medicine wards compared to other wards: a multicentre study 142
Effectiveness of a 23-valent polysaccharide vaccine in preventing pneumonia and non-invasive pneumococcal infection in elderly people: a large-scale retrospective cohort study 142
Pegylated interferon (PEG-IFN) alfa-2b and ribavirin for recurrent hepatitis C (genotype 1) after liver transplantation: relationship with steatosis 141
Interaction between Helicobacter pylori, diet, and genetic polymorphisms as related to non-cancer diseases 141
Latent tuberculosis infection among a large cohort of medical students at a teaching hospital in Italy 141
Totale 17.473
Categoria #
all - tutte 116.268
article - articoli 103.349
book - libri 0
conference - conferenze 8.143
curatela - curatele 0
other - altro 286
patent - brevetti 0
selected - selezionate 0
volume - volumi 4.490
Totale 232.536


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.675 0 0 297 371 84 173 174 769 149 229 107 322
2022/20232.988 299 216 28 293 481 566 27 227 491 31 295 34
2023/20241.660 76 217 29 184 118 239 60 355 104 21 74 183
2024/20254.569 164 337 123 319 560 485 459 701 170 224 436 591
2025/20268.142 940 234 578 587 1.014 791 1.292 371 662 665 460 548
2026/20271.479 764 260 455 0 0 0 0 0 0 0 0 0
Totale 34.651